IP Verse

Hemsath patent opposition analysis

The comprehensive analysis of Hemsath opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Hemsath

Stay updated with the latest patent oppositions filed by Hemsath

Patent NumberTitleApplicantOpposition DateOpposition Company
EP2766040
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEFeb 13, 2020KONIG SZYNKA TILMANN VON RENESSE
EP2971040
Methods Of Cell CultureMOMENTA PHARMACEUTICALSJun 18, 2019BAYER INTELLECTUAL PROPERTY GMBH
EP2270147
Method For Controlling The Activity Of Immunologically Functional MoleculeKYOWA HAKKO KIRINMay 31, 2017KONIG SZYNKA TILMANN VON RENESSE
EP2341078
Monoclonal Antibody Against Rhesus DLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESMay 9, 2017KONIG SZYNKA TILMANN VON RENESSE
EP2270150
Method For Controlling The Activity Of Immunologically Functional MoleculeKYOWA HAKKO KIRINJan 6, 2017KONIG SZYNKA TILMANN VON RENESSE
EP2278003
Method For Controlling The Activity Of Immunologically Functional MoleculeKYOWA HAKKO KIRINDec 16, 2016KONIG SZYNKA TILMANN VON RENESSE
EP1518864
Antibody Against Rhesus DLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESJul 8, 2015KONIG SZYNKA TILMANN VON RENESSE
EP1648513
Use Of Adcc-Optimized Antibodies For Treating Weak PatientsLABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIESJun 24, 2015KONIG SZYNKA TILMANN VON RENESSE
EP1984503
Modified Coagulation Factor Vila With Extended Half-LifeCSL BEHRING GMBHApr 9, 2015KONIG SZYNKA TILMANN VON RENESSE

Top clients of Hemsath

Top companies who are the clients of Hemsath

CompanyTotal
KONIG SZYNKA TILMANN VON RENESSE8
BAYER1
BAYER INTELLECTUAL PROPERTY GMBH1